Bausch + Lomb (BLCO) Financial Analysis & Valuation | Quarter Chart
Bausch + Lomb (BLCO)
BLCOPrice: $15.55
Fair Value: 🔒
🔒score
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, in... more
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three seg... more
Description
Shares
| Market Cap | $5.51B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Instruments & Supplies |
| Country | CA | CEO | Brenton L. Saunders |
| IPO Date | 2022-05-06 | CAGR | 0.05% |
| Employees | 13,500 | Website | www.bausch.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 0.06% | Total Yield | 0.06% |
BLCO chart loading...
Fundamentals
Technicals
| Enterprise Value | $9.34B | P/E Ratio | -18.08 |
| Forward P/E | 15.52 | PEG Ratio | — |
| P/S Ratio | 1.07 | P/B Ratio | 0.82 |
| P/CF Ratio | 27.91 | P/FCF Ratio | -31.47 |
| EPS | $-0.86 | EPS Growth 1Y | -17.18% |
| EPS Growth 3Y | -598.56% | EPS Growth 5Y | — |
| Revenue Growth 1Y | 6.06% | Gross Margin | 0.6% |
| Operating Margin | 0.01% | Profit Margin | -0.08% |
| ROE | -0.06% | ROA | -0.03% |
| ROCE | 0% | Current Ratio | 1.55 |
| Quick Ratio | 0.98 | Cash Ratio | 0.15 |
| Debt/Equity | 0.77 | Interest Coverage | 0.09 |
| Altman Z Score | 0.81 | Piotroski Score | 4 |